Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.86B |
| 2 |
Apple
AAPL
|
+$2.18B |
| 3 |
Microsoft
MSFT
|
+$1.47B |
| 4 |
Amazon
AMZN
|
+$943M |
| 5 |
Alibaba
BABA
|
+$864M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
+$187M |
| 2 |
BFT.U
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
|
+$178M |
| 3 |
NIO
NIO
|
+$156M |
| 4 |
Oracle
ORCL
|
+$151M |
| 5 |
PayPal
PYPL
|
+$148M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 12.05% |
| 4 | Financials | 9.25% |
| 5 | Industrials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Lear
LEA
$5.62B
| $675K | ﹤0.01% |
4,247
-75,411
| -95% | -$12M |
|
3027
EnerSys
ENS
$4B
| $674K | ﹤0.01% |
8,117
-7,659
| -49% | -$636K |
|
|
AMNB
3028
DELISTED
American National Bankshares Inc
AMNB
| $674K | ﹤0.01% |
25,731
+10,173
| +65% | +$266K |
|
3029
ANI Pharmaceuticals
ANIP
$2.12B
| $672K | ﹤0.01% |
+23,152
| New | +$672K |
|
3030
Zumiez
ZUMZ
$347M
| $671K | ﹤0.01% |
+18,254
| New | +$671K |
|
3031
BlackRock Capital Allocation Term Trust
BCAT
$1.6B
| $670K | ﹤0.01% |
+30,793
| New | +$670K |
|
3032
Energizer
ENR
$2.02B
| $669K | ﹤0.01% |
15,859
-351,291
| -96% | -$14.8M |
|
3033
Regenxbio
RGNX
$465M
| $666K | ﹤0.01% |
14,686
+716
| +5% | +$32.5K |
|
|
HPS
3034
John Hancock Preferred Income Fund III
HPS
$483M
| $664K | ﹤0.01% |
+38,401
| New | +$664K |
|
|
SOL
3035
Emeren Group
SOL
$96.5M
| $663K | ﹤0.01% |
57,989
-68,717
| -54% | -$786K |
|
3036
Liberty Media Series A
FWONA
$22.5B
| $662K | ﹤0.01% |
18,206
+1,665
| +10% | +$60.5K |
|
3037
Genmab
GMAB
$17.1B
| $662K | ﹤0.01% |
16,279
-79,315
| -83% | -$3.23M |
|
3038
SPDR S&P Retail ETF
XRT
$436M
| $662K | ﹤0.01% |
10,286
-151,514
| -94% | -$9.75M |
|
|
CSTR
3039
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $662K | ﹤0.01% |
44,874
-10,725
| -19% | -$158K |
|
|
CEO
3040
DELISTED
CNOOC Limited
CEO
| $662K | ﹤0.01% |
+7,223
| New | +$662K |
|
3041
World Acceptance Corp
WRLD
$900M
| $661K | ﹤0.01% |
6,467
+3,943
| +156% | +$403K |
|
3042
The GEO Group
GEO
$3.12B
| $660K | ﹤0.01% |
+74,440
| New | +$660K |
|
3043
Groupon
GRPN
$923M
| $658K | ﹤0.01% |
17,329
-477,486
| -96% | -$18.1M |
|
|
ONIT
3044
Onity Group Inc.
ONIT
$367M
| $658K | ﹤0.01% |
+22,757
| New | +$658K |
|
3045
Immunome
IMNM
$802M
| $657K | ﹤0.01% |
+67,863
| New | +$657K |
|
|
CERE
3046
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $656K | ﹤0.01% |
+39,572
| New | +$656K |
|
3047
Universal Technical Institute
UTI
$1.48B
| $655K | ﹤0.01% |
101,357
-78,580
| -44% | -$508K |
|
3048
ARK Web x.0 ETF
ARKW
$2.45B
| $652K | ﹤0.01% |
+4,455
| New | +$652K |
|
3049
New Mountain Finance
NMFC
$1.11B
| $647K | ﹤0.01% |
56,997
+40,401
| +243% | +$459K |
|
|
FOCS
3050
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $646K | ﹤0.01% |
14,840
-3,204
| -18% | -$139K |
|